JP2014503544A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503544A5
JP2014503544A5 JP2013545540A JP2013545540A JP2014503544A5 JP 2014503544 A5 JP2014503544 A5 JP 2014503544A5 JP 2013545540 A JP2013545540 A JP 2013545540A JP 2013545540 A JP2013545540 A JP 2013545540A JP 2014503544 A5 JP2014503544 A5 JP 2014503544A5
Authority
JP
Japan
Prior art keywords
methyl
alkyl
pyrazol
fluorophenyl
pyrrolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013545540A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014503544A (ja
JP5684923B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/055489 external-priority patent/WO2012085721A1/en
Publication of JP2014503544A publication Critical patent/JP2014503544A/ja
Publication of JP2014503544A5 publication Critical patent/JP2014503544A5/ja
Application granted granted Critical
Publication of JP5684923B2 publication Critical patent/JP5684923B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013545540A 2010-12-20 2011-12-06 カゼインキナーゼ阻害剤としての新規縮合ピリジン化合物 Active JP5684923B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061425213P 2010-12-20 2010-12-20
US61/425,213 2010-12-20
PCT/IB2011/055489 WO2012085721A1 (en) 2010-12-20 2011-12-06 Novel fused pyridine compounds as casein kinase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015005142A Division JP5876596B2 (ja) 2010-12-20 2015-01-14 カゼインキナーゼ阻害剤としての新規縮合ピリジン化合物

Publications (3)

Publication Number Publication Date
JP2014503544A JP2014503544A (ja) 2014-02-13
JP2014503544A5 true JP2014503544A5 (https=) 2015-01-15
JP5684923B2 JP5684923B2 (ja) 2015-03-18

Family

ID=45446116

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013545540A Active JP5684923B2 (ja) 2010-12-20 2011-12-06 カゼインキナーゼ阻害剤としての新規縮合ピリジン化合物
JP2015005142A Active JP5876596B2 (ja) 2010-12-20 2015-01-14 カゼインキナーゼ阻害剤としての新規縮合ピリジン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015005142A Active JP5876596B2 (ja) 2010-12-20 2015-01-14 カゼインキナーゼ阻害剤としての新規縮合ピリジン化合物

Country Status (23)

Country Link
US (1) US8536164B2 (https=)
EP (2) EP2654750B1 (https=)
JP (2) JP5684923B2 (https=)
KR (1) KR101590236B1 (https=)
CN (1) CN103260622B (https=)
AR (1) AR084412A1 (https=)
AU (1) AU2011346733C1 (https=)
CA (1) CA2819961C (https=)
CY (2) CY1118772T1 (https=)
DK (2) DK3181133T3 (https=)
ES (2) ES2744099T3 (https=)
HR (2) HRP20170484T1 (https=)
HU (2) HUE032405T2 (https=)
IL (1) IL226948A (https=)
LT (2) LT3181133T (https=)
MX (1) MX338551B (https=)
PL (2) PL2654750T3 (https=)
PT (2) PT3181133T (https=)
RS (2) RS59098B1 (https=)
SG (1) SG190802A1 (https=)
SI (2) SI3181133T1 (https=)
WO (1) WO2012085721A1 (https=)
ZA (1) ZA201303453B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2493876T1 (sl) * 2009-10-28 2014-04-30 Pfizer Inc. Derivati imidazola kot inhibitorji kazein-kinaze
US9938269B2 (en) 2011-06-30 2018-04-10 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
EP2935272B1 (en) * 2012-12-21 2017-02-22 Bristol-Myers Squibb Company Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors
WO2015163446A1 (ja) * 2014-04-25 2015-10-29 協和発酵キリン株式会社 イミダゾール化合物の製造方法
JP2017222576A (ja) * 2014-10-31 2017-12-21 石原産業株式会社 有害生物防除剤
CN107365315B (zh) * 2016-05-11 2024-08-09 国药集团国瑞药业有限公司 一种吡唑类化合物、其晶型及其制备方法
US10973820B2 (en) * 2017-12-13 2021-04-13 Facio Intellectual Property B.V. Compounds for treatment of diseases related to DUX4 expression
TW202112368A (zh) * 2019-06-13 2021-04-01 荷蘭商法西歐知識產權股份有限公司 用於治療有關dux4表現之疾病的抑制劑組合
CN115335057A (zh) * 2020-03-27 2022-11-11 北京原基华毅生物科技有限公司 抑制酪蛋白激酶的方法
EP4126878A4 (en) * 2020-03-27 2024-07-10 Gritscience Biopharmaceuticals Co., Ltd. COMPOUNDS AS CASEIN KINASE INHIBITORS
AR122711A1 (es) 2020-06-25 2022-09-28 Alchemedicine Inc COMPUESTO HETEROCÍCLICO COMO INHIBIDOR DE CASEÍNA QUINASA 1d Y/O QUINASA 5 TIPO RECEPTOR DE ACTIVINA
CN111808102B (zh) * 2020-08-03 2021-12-31 南通大学 一种3-甲氧基-6,7-二氢-5H-吡咯并[3,4-b]吡啶盐酸盐及其合成方法
JP2023541465A (ja) * 2020-09-17 2023-10-02 ヤンセン ファーマシューティカ エヌ.ベー. カゼインキナーゼ1デルタモジュレーター
KR20230069169A (ko) * 2020-09-17 2023-05-18 얀센 파마슈티카 엔.브이. 카제인 키나제 1 델타 조절제
EP4251149A4 (en) * 2020-11-24 2024-10-30 Merck Sharp & Dohme LLC MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
CN116888126B (zh) * 2020-12-15 2026-03-17 北京原基华毅生物科技有限公司 一种酪蛋白激酶抑制剂的化合物
US20230053307A1 (en) * 2021-07-19 2023-02-16 Buddhist Tzu Chi Medical Foundation Method for preventing or treating skin disorders and conditions
CN119487030A (zh) * 2022-06-14 2025-02-18 北京原基华毅生物科技有限公司 作为酪蛋白激酶抑制剂的化合物的盐和/或晶形
CN117362303B (zh) * 2022-07-02 2026-02-03 黑龙江联顺生物科技有限公司 一种生物素中间体环酐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151962A3 (en) 1984-01-25 1985-10-02 Beecham Group Plc Pyrazolopyridine derivatives
PL337020A1 (en) * 1997-05-22 2000-07-31 Searle & Co Substituted pyrazoles as kinase p38 inhibitors
WO2001046196A1 (en) * 1999-12-21 2001-06-28 Sugen, Inc. 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
BRPI0612112A8 (pt) 2005-06-22 2017-12-26 Chemocentryx Inc composto, composição farmacêutica, e, método de tratar doenças ou condições mediadas por ccr1.
WO2007140213A1 (en) 2006-05-26 2007-12-06 Forest Laboratories Holdings Limited Pyridoazepine derivatives
EP2308866A1 (de) * 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
SI2493876T1 (sl) * 2009-10-28 2014-04-30 Pfizer Inc. Derivati imidazola kot inhibitorji kazein-kinaze

Similar Documents

Publication Publication Date Title
JP2014503544A5 (https=)
JP7654071B2 (ja) 複素環スピロ化合物及び使用方法
JP6770127B2 (ja) Btk阻害薬としての一級カルボキサミド類
HRP20170484T1 (hr) Novi kondenzirani spojevi piridina kao inhibitori kazeinske kinaze
AU2017204248B2 (en) Compounds for treating spinal muscular atrophy
JP2014513139A5 (https=)
US10975080B2 (en) Compounds and compositions for inhibiting the activity of SHP2
JP7399848B2 (ja) Rho関連コイルドコイル含有プロテインキナーゼの阻害剤
TWI579284B (zh) 咪唑并吡咯啶酮化合物
RU2665036C9 (ru) Гетероароматические соединения-модуляторы фосфоинозидит-3-киназы и способы применения
JP2017510576A5 (https=)
JP2019536768A5 (https=)
RU2018134981A (ru) Конъюгаты, содержащие ингибиторы RIPK2
RU2015105249A (ru) Ингибиторы mtor киназы для онкологических показаний и заболеваний, связанных с mtor/pi3k/akt путем метаболизма
RU2014112931A (ru) Пиразолохинолиновое производное
JP2014513140A5 (https=)
JP2013512953A5 (https=)
JP2020526549A5 (https=)
EP3393472A1 (en) 3-(1h-pyrazol-4-yl)pyridine allosteric modulators of the m4 muscarinic acetylcholine receptor
JP2017513887A5 (https=)
JP2019504102A5 (https=)
JP2013518823A5 (https=)
JP2016517877A5 (https=)
SI2864328T1 (en) Pharmaceutically active compounds
WO2019005587A1 (en) ACETYLCHOLINE M4 MUSCARINIC RECEPTOR TYPE 3- (1H-PYRAZOL-4-YL) PYRIDINE MODULATORS